Effect of Modafinil on Fatigue Associated with Neurological Illnesses
- 1 January 2000
- journal article
- Published by The Haworth Press in Journal of Chronic Fatigue Syndrome
- Vol. 8 (2) , 65-70
- https://doi.org/10.1300/j092v08n02_06
Abstract
Fatigue is a common symptom of a variety of neurological illnesses, such as Alzheimer's disease, chronic fatigue syndrome, multiple sclerosis, Parkinson's disease, and stroke. Fatigue severely impairs productivity, performance, social functioning, and quality of life. Modafinil (PROVIGIL(r)) has been shown to significantly improve fatigue associated with multiple sclerosis and depression. Here, a retrospective review of the medical charts of 25 patients treated with modafinil for fatigue associated with various neurological illnesses was conducted. Modafinil was effective for the treatment of fatigue in 21 of 25 patients (84%), and was well tolerated. Therefore, modafinil appears to be a potentially attractive candidate for the treatment of fatigue associated with neurological disorders.Keywords
This publication has 5 references indexed in Scilit:
- Fatigue in patients with Parkinson's diseaseMovement Disorders, 1999
- Chronic Fatigue Syndrome: An UpdateAnnual Review of Medicine, 1998
- Role of catecholamines in the modafinil and amphetamine induced wakefulness, a comparative pharmacological study in the catBrain Research, 1992
- Successful treatment of idiopathic hypersomnia and narcolepsy with modafinilProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1988
- Amantadine Therapy for Fatigue in Multiple SclerosisCanadian Journal of Neurological Sciences, 1985